EU reaches deal with Moderna on COVID-19 vaccine supply

Grant Boone
November 25, 2020

The Serum Institute of India is aiming to have 100 million doses ready by December for an inoculation drive and the country will be given first priority for delivery of the AstraZeneca-Oxford vaccine.

After Pfizer submitted its application for a COVID-19 vaccine to the U.S. Food and Drug Administration last week, IL public health officials have continued preparing locations to store and distribute the vaccine that could be released to frontline hospital workers in a matter of weeks. Since January, it has delivered more than $190 million worth of Covid-19 supplies such as masks, gowns, oxygen concentrators and diagnostic test kits in support of countries as they respond to the pandemic.

"We are very hopeful we are about to receive more data that includes clinical data in the next week", Simão said.

According to the company, the vaccine is 95 per cent effective and will cost less than $10 or Rs 740 internationally.

"It will be another two to three months for the vaccine to be available in India".

Last weekend was the busiest since the start of the pandemic with more than three million people passing through U.S. airports, according to the Transportation Security Administration, which is responsible for security checks.

By the end of the first quarter of the next year, AstraZeneca has predicted that it will have 300 million finished doses available across the world.

But Naor Bar-Zeev, PhD, of the International Vaccine Access Center at Johns Hopkins University in Baltimore, cautioned against trying to compare them that soon.

Call of Duty's New Nuketown '84 Map Launches Tomorrow
The classic COD map returns with a Black Ops Cold War Twist and brings back the original high-octane gameplay to the title. There is also a commemorative bundle being offered to celebrate the release of Nuketown, and you can claim it for free.

SII scientists are, in fact, hopeful of being able to roll out the vaccine before the year is out.

Basically, the first group of recipients usually go to frontline healthcare workers and also people with high risks of transmission, said the department.

"According to the results of clinical trials, this vaccine could be highly effective against Covid-19", European Commission President Ursula von der Leyen said.

"The combined analysis from both dosing regimens resulted in an average efficacy of 70%".

World Health Organization officials await further trial data on safety and efficacy (iStock).

Most experts, as well as scattered members and hints from the CDC's Advisory Committee on Immunization Practices (ACIP) suggest the shot will like likely be rolled out to health care workers first.

Last month, President Vladimir Putin announced that Russian Federation had registered a second coronavirus vaccine, EpiVacCorona, as a global race heats up in producing an effective vaccine to combat the pandemic, which has now claimed the lives of almost 1.4 million people. Since its 2 dose vaccine, the total cost is expected to be around 1480.

Moderna's coronavirus vaccine may not get life back to normal right away because it hasn't yet been proven to prevent the deadly bug from spreading, the company's top doctor says.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER